These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 1940657

  • 1. [Improvement of hemorheologic parameters in hemodialyzed patients treated with human recombinant erythropoietin].
    Delamaire M, Durand F, Hamel D, Joyeux V, Lepogamp P, Genetet B.
    J Mal Vasc; 1991; 16(3):289-94. PubMed ID: 1940657
    [Abstract] [Full Text] [Related]

  • 2. Blood rheology in hemodialysis patients treated with recombinant human erythropoietin.
    Brunner R, Pollok M, Heidel M, Müller R, Degenhardt S, Baldamus CA.
    Contrib Nephrol; 1989; 76():306-12; discussion 312-4. PubMed ID: 2582784
    [No Abstract] [Full Text] [Related]

  • 3. Haemorheological changes in uraemic children in response to erythropoietin treatment.
    Böhler T, Leo A, Linderkamp O, Braun A, Schärer K.
    Nephrol Dial Transplant; 1993; 8(2):140-5. PubMed ID: 8384334
    [Abstract] [Full Text] [Related]

  • 4. Hemorheological changes in solid tumor patients after treatment with recombinant erythropoetin.
    Muravyov AV, Cheporov SV, Kislov NV, Volkova EL.
    Clin Hemorheol Microcirc; 2009; 41(1):39-47. PubMed ID: 19136741
    [Abstract] [Full Text] [Related]

  • 5. [Hemorheologic parameters in patients with giant cell arteritis before and after treatment with steroids].
    Wiek J, Krause M, Wiederholt M, Hansen LL.
    Fortschr Ophthalmol; 1990; 87(6):671-4. PubMed ID: 2086417
    [Abstract] [Full Text] [Related]

  • 6. Hemorheological improvement after Daflon 500 mg treatment in diabetes.
    Lacombe C, Bucherer C, Lelievre JC.
    Int Angiol; 1988; 7(2 Suppl):21-4. PubMed ID: 3183453
    [Abstract] [Full Text] [Related]

  • 7. Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin.
    Koppensteiner R, Stockenhuber F, Jahn C, Balcke P, Minar E, Ehringer H.
    BMJ; 1990 Jun 23; 300(6740):1626-7. PubMed ID: 2372642
    [No Abstract] [Full Text] [Related]

  • 8. Hemorheological and hemodynamic changes in predialysis patients after normalization of hemoglobin with epoetin-alpha.
    Furuland H, Linde T, Sandhagen B, Andrén B, Wikström B, Danielson BG.
    Scand J Urol Nephrol; 2005 Jun 23; 39(5):399-404. PubMed ID: 16257842
    [Abstract] [Full Text] [Related]

  • 9. Does additional treatment with fish oil mitigate the side effects of recombinant human erythropoietin in dialysis patients?
    de Fijter CW, Popp-Snijders C, Oe LP, Tran DD, van der Meulen J, Donker AJ.
    Haematologica; 1995 Jun 23; 80(4):332-4. PubMed ID: 7590502
    [Abstract] [Full Text] [Related]

  • 10. Blood rheology and 2,3-diphosphoglycerate levels after erythropoietin treatment.
    Crowley JP, Chazan JA, Metzger JB, Pono L, Valeri CR.
    Ann Clin Lab Sci; 1993 Jun 23; 23(1):24-32. PubMed ID: 8430997
    [Abstract] [Full Text] [Related]

  • 11. [Hemo-rheologic changes following treatment with human recombinant erythropoietin in chronic hemodialysis patients].
    Melappioni M, Giansanti R, Boemi M, Baldassari M, Baldini S, Pierangeli T, Radicioni R, Fumelli P, Panichi N.
    Minerva Urol Nefrol; 1992 Jun 23; 44(2):155-9. PubMed ID: 1411865
    [Abstract] [Full Text] [Related]

  • 12. The relation between the erythrocyte nitric oxide and hemorheological parameters.
    Carvalho FA, Maria AV, Braz Nogueira JM, Guerra J, Martins-Silva J, Saldanha C.
    Clin Hemorheol Microcirc; 2006 Jun 23; 35(1-2):341-7. PubMed ID: 16899954
    [Abstract] [Full Text] [Related]

  • 13. Long-term effects of rhEPO therapy on erythrocyte rheology in dialysis patients with different target hematocrits.
    Paulitschke M, Ludat K, Riedel E, Hampl H.
    Clin Nephrol; 2000 Feb 23; 53(1 Suppl):S36-41. PubMed ID: 10746804
    [Abstract] [Full Text] [Related]

  • 14. Hemorheological parameters in children with iron-deficiency anemia and the alterations in these parameters in response to iron replacement.
    Halis H, Bor-Kucukatay M, Akin M, Kucukatay V, Bozbay I, Polat A.
    Pediatr Hematol Oncol; 2009 Feb 23; 26(3):108-18. PubMed ID: 19382032
    [Abstract] [Full Text] [Related]

  • 15. Effect of erythropoietin treatment on tissue oxygenation in patients with severe transfusion dependent renal anaemia.
    Landgraf H, Grützmacher P, Garcia-Bartels C, Bergmann M, Ehrly AM, Schoeppe W.
    Eur J Med; 1993 Feb 23; 2(7):393-7. PubMed ID: 8258026
    [Abstract] [Full Text] [Related]

  • 16. [Recombinant human erythropoietin (rh-EPO) in chronic, dialysis-dependent renal failure: effects on macro- and microcirculation and hematologic parameters].
    Köhler M, Mörsdorf S, Jung F, Braun B, Waldhausen P, Pindur G, Weber U, Bosslet R, Bambauer R, Jutzler GA.
    Beitr Infusionsther; 1990 Feb 23; 26():89-95. PubMed ID: 1703909
    [Abstract] [Full Text] [Related]

  • 17. The effect of simvastatin therapy on hemorheological profile in coronary heart desease (CHD) patients.
    Muravyov AV, Yakusevich VV, Surovaya L, Petrochenko A.
    Clin Hemorheol Microcirc; 2004 Feb 23; 31(4):251-6. PubMed ID: 15567894
    [Abstract] [Full Text] [Related]

  • 18. Effect of penicillin G-induced epileptic seizures on hemorheological parameters in rats.
    Adigüzel E, Küçükatay V, Erken G, Yonguç N, Bor-Küçükatay M.
    Life Sci; 2006 Nov 17; 79(25):2382-6. PubMed ID: 16920157
    [Abstract] [Full Text] [Related]

  • 19. [The effect of recombinant erythropoietin on candidicidal activity of polymorphonuclear leukocytes in hemodialyzed patients].
    Bartůnková J, Sulková S, Cebecauer M.
    Cas Lek Cesk; 1995 Dec 06; 134(23):756-9. PubMed ID: 8599817
    [Abstract] [Full Text] [Related]

  • 20. Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia.
    Fujita Y, Inoue S, Horiguchi S, Kuki A.
    Miner Electrolyte Metab; 1995 Dec 06; 21(1-3):50-4. PubMed ID: 7565462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.